Ignite Creation Date:
2024-07-17 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465563
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-06-13
Brief Title:
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
Sponsor:
Suzhou Suncadia Biopharmaceuticals Co Ltd
Organization:
Suzhou Suncadia Biopharmaceuticals Co Ltd
Organization Data
Organization:
Suzhou Suncadia Biopharmaceuticals Co Ltd
Class:
INDUSTRY
Study ID:
SHR-8068-201-BTC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Suzhou Suncadia Biopharmaceuticals Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None